Rx (Prescription Medicine)
USD $ 13.00
Cytosar 500 mg 注射剂含有 Cytarabine，是一种化疗药物，通过抑制癌细胞生长来治疗各类白血病和淋巴瘤。它在医生监督下静脉或皮下给药。
Cytosar 500 mg 注射剂是治疗多种癌症的重要药物。其活性成分 Cytarabine 是一种细胞毒性化疗药物，通过干扰快速分裂细胞的 DNA 合成，从而抑制癌细胞生长。Cytosar 主要用于诱导急性髓系白血病 (AML) 缓解，以及治疗急性淋巴细胞白血病 (ALL) 和淋巴瘤。它也用于其他类型白血病和某些实体瘤的联合治疗。Cytosar 500 mg 注射剂的剂量和给药方式由主治医生根据具体癌症类型和分期，以及患者的整体健康状况和治疗反应来决定。常见副作用可能包括骨髓抑制导致血细胞计数下降（贫血、中性粒细胞减少、血小板减少）、恶心、呕吐、腹泻和脱发。患者应密切监测这些反应。Cytosar 500 mg 注射剂应在室温下保存，避光，并放在儿童接触不到的地方。
| Molecule | Cytarabine |
|---|---|
| Strength | 500 mg |
| Pack Quantity | 1 Vial |
| Medicine Form | Injection |
| Medicine Type | Chemotherapy |
| Rx Status | Prescription Required |
| Country Of Origin | India |
| Packaging Type | Vial |
| Brand Name | Cytosar |
只有已购买此产品的登录客户才能发表评价。
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Cytarabine. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
评价
目前还没有评价